Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral hemorrhagic fevers.

Aileen M Marty1, Peter B Jahrling, Thomas W Geisbert

  • 1Battelle Memorial Institute, Suite 601, 1550 Crystal Drive, Arlington, VA 22202-4172, USA. martya@battelle.org

Clinics in Laboratory Medicine
|July 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccine.

bioRxiv : the preprint server for biology·2026
Same author

Vertical transmission of Nipah virus in an experimentally infected nonhuman primate; a brief report and description of histopathological lesions.

The Journal of infectious diseases·2026
Same author

Marburg virus disease: a comprehensive review.

Clinical microbiology reviews·2026
Same author

Recombinant Bombali ebolavirus in cynomolgus macaques as a survival model of Ebola virus disease.

Nature communications·2026
Same author

Progression of nipah virus infection in the African green monkey: Role of macrophages and dendritic cells in early virus spread.

iScience·2026
Same author

Hemorrhagic Fever Disease in STAT-1 Knockout Mice Infected with Lujo Virus.

Pathogens (Basel, Switzerland)·2026
Same journal

Advances in Hemostasis Laboratory Testing.

Clinics in laboratory medicine·2026
Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026
Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026
Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026
Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026
See all related articles

Viral hemorrhagic fever (VHF) is a severe systemic febrile syndrome caused by diverse single-stranded ribonucleic acid (ssRNA) viruses. Current treatments are limited, highlighting the urgent need for new vaccines and drugs against VHF.

Area of Science:

  • Virology
  • Pathology
  • Immunology

Background:

  • Viral hemorrhagic fever (VHF) is an acute systemic febrile illness caused by ssRNA viruses from Arenaviridae, Bunyaviridae, Filoviridae, and Flaviviridae families.
  • VHF presents with prostration, malaise, increased vascular permeability, and coagulation disorders, with bleeding as a sign of vascular endothelium damage and disease severity.

Purpose of the Study:

  • To summarize the current understanding of VHF pathogenesis.
  • To highlight the lack of available vaccines and therapeutics for most VHFs.

Main Methods:

  • Review of existing literature on VHF viral families and pathogenesis.
  • Analysis of disease mechanisms, including viral replication and host immune responses.

Main Results:

Related Experiment Videos

  • VHF pathogenesis involves viral replication in endothelial cells and mediator release from infected monocytes/macrophages, leading to vascular and coagulation abnormalities.
  • Despite progress in understanding molecular biology, no licensed vaccines or drugs exist for most VHFs.

Conclusions:

  • VHF poses a significant global health threat due to its diverse viral etiologies and severe clinical manifestations.
  • The absence of effective treatments underscores the critical need for developing novel vaccines and antiviral therapies to combat VHF.